5-33988117-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014324.6(AMACR):​c.*976G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00989 in 526,660 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0085 ( 10 hom., cov: 33)
Exomes 𝑓: 0.010 ( 46 hom. )

Consequence

AMACR
NM_014324.6 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.00900
Variant links:
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 5-33988117-C-T is Benign according to our data. Variant chr5-33988117-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 353240.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00852 (1297/152302) while in subpopulation SAS AF = 0.0313 (151/4826). AF 95% confidence interval is 0.0272. There are 10 homozygotes in GnomAd4. There are 662 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMACRNM_014324.6 linkc.*976G>A 3_prime_UTR_variant Exon 5 of 5 ENST00000335606.11 NP_055139.4 Q9UHK6-1
AMACRNM_001167595.2 linkc.*191G>A 3_prime_UTR_variant Exon 6 of 6 NP_001161067.1 Q9UHK6-5
AMACRNM_203382.3 linkc.*1367G>A 3_prime_UTR_variant Exon 4 of 4 NP_976316.1 Q9UHK6-4
C1QTNF3-AMACRNR_037951.1 linkn.2481G>A non_coding_transcript_exon_variant Exon 9 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMACRENST00000335606.11 linkc.*976G>A 3_prime_UTR_variant Exon 5 of 5 1 NM_014324.6 ENSP00000334424.6 Q9UHK6-1
C1QTNF3-AMACRENST00000382079.3 linkn.*1551G>A non_coding_transcript_exon_variant Exon 9 of 9 2 ENSP00000371511.3 E9PGA6
C1QTNF3-AMACRENST00000382079.3 linkn.*1551G>A 3_prime_UTR_variant Exon 9 of 9 2 ENSP00000371511.3 E9PGA6

Frequencies

GnomAD3 genomes
AF:
0.00854
AC:
1299
AN:
152184
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00251
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0186
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.0317
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.00919
Gnomad OTH
AF:
0.0148
GnomAD4 exome
AF:
0.0104
AC:
3911
AN:
374358
Hom.:
46
Cov.:
4
AF XY:
0.0112
AC XY:
2174
AN XY:
194648
show subpopulations
African (AFR)
AF:
0.00320
AC:
36
AN:
11252
American (AMR)
AF:
0.0158
AC:
255
AN:
16090
Ashkenazi Jewish (ASJ)
AF:
0.0182
AC:
214
AN:
11734
East Asian (EAS)
AF:
0.000704
AC:
20
AN:
28390
South Asian (SAS)
AF:
0.0255
AC:
695
AN:
27286
European-Finnish (FIN)
AF:
0.00129
AC:
32
AN:
24786
Middle Eastern (MID)
AF:
0.0333
AC:
88
AN:
2640
European-Non Finnish (NFE)
AF:
0.00997
AC:
2293
AN:
229908
Other (OTH)
AF:
0.0125
AC:
278
AN:
22272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
179
357
536
714
893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00852
AC:
1297
AN:
152302
Hom.:
10
Cov.:
33
AF XY:
0.00889
AC XY:
662
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00253
AC:
105
AN:
41566
American (AMR)
AF:
0.0186
AC:
284
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3464
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5186
South Asian (SAS)
AF:
0.0313
AC:
151
AN:
4826
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10614
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.00916
AC:
623
AN:
68022
Other (OTH)
AF:
0.0156
AC:
33
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
70
140
210
280
350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00813
Hom.:
2
Bravo
AF:
0.00916
Asia WGS
AF:
0.0210
AC:
75
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Alpha-methylacyl-CoA racemase deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
2.3
DANN
Benign
0.50
PhyloP100
0.0090
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs150664086; hg19: chr5-33988222; API